I am a
Home I AM A Search Login

RFA-TR-22-013: Emergency Awards: HEAL Initiative – New Innovator Award (DP2 Clinical Trial Not Allowed)


25 January 2022


PRF Funding Opportunities

IASP News

RFA-TR-22-013: Emergency Awards: HEAL Initiative – New Innovator Award(DP2 Clinical Trial Not Allowed)

First application due date: February 28, 2022 with additional due dates later in the year and in 2023. 

 The Helping End Addiction Long-Term (HEAL) New Innovator Award supports a postdoctoral or newly independent Early Stage Investigator of exceptional creativity who proposes novel, original and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research related to pain, opioid use disorder (OUD), and/or overdose (OD). Applications proposing unexpected convergence of disciplines, new scientific directions, or the use of novel methodologies are encouraged.

 

Learn more: https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-22-013.html

Share This